• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:郭切切,张舒迪,邵艳寻,郭晨曦,杨雅欣,刘占军.还原响应型靶向自载药纳米粒的制备及其体外评价[J].中国现代应用药学,2022,39(19):2511-2520.
GUO Qieqie,ZHANG Shudi,SHAO Yanxun,GUO Chenxi,YANG Yaxin,LIU Zhanjun.Preparation and in Vitro Evaluation of Reduction-responsive Targeting Self-loaded Nanoparticle[J].Chin J Mod Appl Pharm(中国现代应用药学),2022,39(19):2511-2520.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 944次   下载 682 本文二维码信息
码上扫一扫!
分享到: 微信 更多
还原响应型靶向自载药纳米粒的制备及其体外评价
郭切切, 张舒迪, 邵艳寻, 郭晨曦, 杨雅欣, 刘占军
华北理工大学药学院, 河北 唐山 063210
摘要:
目的 制备靶向性的自载药纳米粒(HA-ss-Bai NPs),并考察其作为药物载体递送姜黄素(curcumin,Cur)的可行性。方法 制备二硫键连接的透明质酸(hyaluronic acid,HA)-黄芩苷(baicalin,Bai)聚合物,利用核磁共振氢谱(hydrogen nuclear magnetic resonance spectroscopy,1H-NMR)、红外光谱(infrared spectroscopy,IR)确证聚合物的结构;采用超声法制备自组装纳米粒,并对其粒径、Zeta电位进行表征;采用芘荧光探针法测定纳米粒的临界聚集浓度(critical aggregation concentration,CAC);测定载Cur纳米粒包封率和载药量;MTT试验考察载药纳米粒的体外抗肿瘤活性。结果 制备HA-ss-Bai NPs,最小粒径为(124.3±6.5) nm,CAC值为(0.023 8±0.003 5) mg·mL–1。测得Cur/HA-ss-Bai NPs的粒径为(172.5±3.2) nm,载药量为(17.08±0.25)%,包封率为(51.23±3.97)%。体外释放表明药物在还原条件下可快速释放,MTT试验表明Cur/HA-ss-Bai NPs对HepG2肝癌细胞生长具有显著的抑制作用。结论 制备的Cur/HA-ss-Bai NPs粒径均匀、载药量较高,具有良好的还原响应性和抗肿瘤活性,同时提高了Bai与Cur的体外抗肿瘤效果。
关键词:  透明质酸  二硫键  黄芩苷  自载药  还原响应
DOI:10.13748/j.cnki.issn1007-7693.2022.19.012
分类号:R943
基金项目:河北省自然科学基金(H2021209024,H2018209347)
Preparation and in Vitro Evaluation of Reduction-responsive Targeting Self-loaded Nanoparticle
GUO Qieqie, ZHANG Shudi, SHAO Yanxun, GUO Chenxi, YANG Yaxin, LIU Zhanjun
College of Pharmacy, North China University of Science and Technology, Tangshan 063210, China
Abstract:
OBJECTIVE To prepare self-loaded drug nanoparticles (HA-ss-Bai NPs) with reduction responsiveness and tumor-targeting properties,and to investigate their feasibility as a drug carrier to deliver curcumin (Cur).METHODS The polymer hyaluronic acid (HA)-baicalin (Bai) connected by disulfide bonds was synthesized,and its structure was confirmed by hydrogen nuclear magnetic resonance spectroscopy (1H-NMR) and infrared spectroscopy (IR).The self-assembled nanoparticles were prepared by the ultrasound method,their particle size and Zeta potential were characterized,and their critical aggregation concentration (CAC) was determined by the pyrene fluorescence probe method;the encapsulation efficiency and drug loading amount of nanoparticles loaded with Cur were determined.The anti-tumor activity in vitro of drug-loaded nanoparticles was assessed by MTT assay.RESULTS HA-ss-Bai NPs were prepared,the minimum particle size was (124.3±6.5) nm,CAC value was (0.023 8±0.003 5) mg·mL–1.The particle size of Cur/HA-ss-Bai NPs was (172.5±3.2) nm,drug loading was (17.08±0.25)%,encapsulation efficiency was (51.23±3.97)%.The in vitro release showed that the drug could be released quickly under reducing conditions.The MTT experiment indicated that Cur/HA-ss-Bai NPs had a significant inhibitory effect on the growth of HepG2 liver cancer cells.CONCLUSION The Cur/HA-ss-Bai NPs have uniform particle size,with high drug loading,good reduction responsiveness and anti-cancer activity.The anti-tumor effect of Bai and Cur in vitro is improved.
Key words:  hyaluronic acid  disulfide bond  baicalin  self-loaded drug  reduction response
扫一扫关注本刊微信